← Leaderboards
Saumendra N Sarkar
University Of Pittsburgh At Pittsburgh
$6,788,497
Attributed
$9,054,842
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,054,842 · 5
By mechanism
R01$7,594,754 · 4
U24$1,460,088 · 1
Top collaborators
- Michael S. Diamond6 shared
- Vijay Rathinam3 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Joseph C. Glorioso$19,383,290
- Stephen H Thorne$3,784,781
- Wen Xie$22,052,503
- Michael S. Diamond$85,358,908
- Pamela A Moalli$8,505,235
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsMediatingGenesVirus DiseasesSignal TransductionHost DefenseNatural ImmunityInfectionImmune ResponseIn VivoViralIn VitroShapesOligoadenylateInterferonsPlayBiochemicalPredispositionResponseLigaseCell TypeProteinsBaseImmune
Grant awards (23)
New roles of IFN-inducible OAS proteins in innate immune defense against bacterial infections$616,500
R01 · FY2025 · AI · contact PI
New roles of IFN-inducible OAS proteins in innate immune defense against bacterial infections$637,370
R01 · FY2024 · AI · contact PI
A new mechanism of antiviral activity of 2-5 Oligoadenylate Synthetase 1$323,830
R01 · FY2024 · AI · contact PI
A new mechanism of antiviral activity of 2'-5' Oligoadenylate Synthetase 1$40,469
R01 · FY2024 · AI · contact PI
New roles of IFN-inducible OAS proteins in innate immune defense against bacterial infections$686,721
R01 · FY2023 · AI · contact PI
A new mechanism of antiviral activity of 2'-5' Oligoadenylate Synthetase 1$362,789
R01 · FY2023 · AI · contact PI
A new mechanism of antiviral activity of 2'-5' Oligoadenylate Synthetase 1$603,822
R01 · FY2022 · AI · contact PI
A new mechanism of antiviral activity of 2'-5' Oligoadenylate Synthetase 1$634,610
R01 · FY2021 · AI · contact PI
A new mechanism of antiviral activity of 2â-5â Oligoadenylate Synthetase 1$626,580
R01 · FY2020 · AI · contact PI
Differential modulation of RIG-I and cGAS signaling by OASL and its role in antiviral response.$400,401
R01 · FY2019 · AI · contact PI
Differential modulation of RIG-I and cGAS signaling by OASL and its role in antiviral response.$449,301
R01 · FY2018 · AI · contact PI
Creation of Immuno-Oncolytic Viruses for Cancer Therapy$319,550
R01 · FY2018 · CA · contact PI
Differential modulation of RIG-I and cGAS signaling by OASL and its role in antiviral response.$450,513
R01 · FY2017 · AI · contact PI
Creation of Immuno-Oncolytic Viruses for Cancer Therapy$319,550
R01 · FY2017 · CA · contact PI
Differential modulation of RIG-I and cGAS signaling by OASL and its role in antiviral response.$377,491
R01 · FY2016 · AI · contact PI
Creation of Immuno-Oncolytic Viruses for Cancer Therapy$319,550
R01 · FY2016 · CA · contact PI
Differential modulation of RIG-I and cGAS signaling by OASL and its role in antiviral response$47,997
R01 · FY2016 · AI · contact PI
Differential modulation of RIG-I and cGAS signaling by OASL and its role in antiviral response.$377,710
R01 · FY2015 · AI · contact PI
Novel Modifiers of Toll-like and RIG-like Receptor Signaling$267,931
U24 · FY2013 · AI · contact PI
Novel Modifiers of Toll-like and RIG-like Receptor Signaling$285,032
U24 · FY2012 · AI · contact PI
Novel Modifiers of Toll-like and RIG-like Receptor Signaling$285,144
U24 · FY2011 · AI · contact PI
Novel Modifiers of Toll-like and RIG-like Receptor Signaling$288,015
U24 · FY2010 · AI · contact PI
Novel Modifiers of Toll-like and RIG-like Receptor Signaling$333,966
U24 · FY2009 · AI · contact PI